Not All Disabilities are Visible
Navigating the world as a disabled person is not easy, even with the ADA compliance regulations put in place.
Automation of Healthcare Documentation – a Blessing or Pandora’s Box?
The documentation-free, touch-free, human-free future of healthcare will come with its own set of unique stressors.
We May Soon Have a Nitazene Crisis
A drug testing service reported that, since September, nitazenes were found in 20 samples of black market benzodiazepines.
Addiction Isn’t Just Genetic
The impact of behavioral factors on addiction is a complex and multifaceted topic that continues to be researched and explored.
For the Love of 4am
Many individuals are constantly searching for ways to maximize their output and achieve more in their personal and professional lives.
The Gut Healthy Diet
Emerging research suggests that our microbial composition can impact our nutritional needs and even influence our dietary choices.
Benefits of Mixing Running and Walking
Incorporating both running and walking into your exercise routine can offer numerous science-backed benefits for your health.
Master Emotional Self-Regulation
Learning how to process emotions and respond with appropriate behavior is essential to a person’s well-being.
Sleep Hygiene: A Gift to Your Mental Health
Poor sleep hygiene practices disrupt the normal balance of the sleep-wake cycle and are associated with sleep problems.
Heal Relationships During the Holidays
The holiday season is often portrayed as a time of love, joy, and peace. However, for many, it can also ...
Don’t Fall for Political Hate on Health Policy
We release the transcript of a recent video where we discuss how politicians use hateful rhetoric to simplify health policy.
Coding & Billing for SDOH
The summary document details the changes and updates made in the Medicare Physician Fee Schedule Final Rule for CY 2024.
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more